L452R and Y453F SARS-CoV-2 mutations increase transmission and evade immunity
Mutations from the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) have created multiple variants. Some variants, such as those found
Read more
Mutations from the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) have created multiple variants. Some variants, such as those found
Read moreIn a methodologically ‘state-of-the-art’ approach, US researchers have developed a protein-based nanoparticle vaccine against coronavirus disease (COVID-19), with a swift
Read moreA technical report recently published by the European Center for Disease Prevention and Control (ECDC) has summarized all available literature
Read moreIn a new study published in Emergent Materials, researchers show how microfluidic systems integrated with quantum dot-based affinity biosensors can
Read moreLipid nanoparticles (LNPs) are the carrier vehicles that protect messenger RNA (mRNA) molecules from degradation and aid intracellular delivery and
Read moreA recent study, currently available on the bioRxiv* preprint server, indicates that a pair of dual-action monoclonal antibodies derived from
Read moreCOVID-19 (coronavirus disease 2019) is caused by a new positive-strand RNA coronavirus, the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2),
Read moreResearchers in the United States and South Africa report that the NVX-CoV2373 vaccine from Novavax has proved effective at preventing
Read moreResearchers found a small molecule that inhibits different virus proteins and significantly reduces infection in cells. Combined with the antiviral
Read moreThe clinical phenotype of coronavirus disease 2019 (COVID-19), caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), is remarkable
Read more